Turka Laurence A. 4
4 · Rubius Therapeutics, Inc. · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Turka Laurence A.
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2021-01-29+29,750→ 29,750 total→ Common Stock (29,750 underlying) - Award
Stock Option (Right to Buy)
2021-01-29+131,250→ 131,250 totalExercise: $11.97Exp: 2031-01-28→ Common Stock (131,250 underlying)
Footnotes (3)
- [F1]25% of this option shall vest on January 29, 2022, then in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The shares underlying the restricted stock units will vest in four equal annual installments beginning on January 29, 2022.